Peer-reviewed veterinary case report
Epidermal growth factor speeds ear drum healing in dogs
By Lee, Yujin & Bae, Seulgi·Published in Veterinary dermatology·2026·Department of Veterinary Internal Medicine, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effect of Epidermal Growth Factor on Tympanic Membrane Epithelial Migration in Canine Models.
- Species:
- dog
Plain-English summary
Three male beagle dogs were treated with a topical solution containing epidermal growth factor (EGF) to see if it could speed up the healing of their ear membranes. The dogs received EGF weekly for two weeks, and researchers found that the rate of epithelial migration in the ear membranes was significantly faster with EGF compared to no treatment. Specifically, the EGF treatment increased the healing rate by about 60%. There were no side effects noted during the study, suggesting that EGF could be a promising option for helping dogs recover from ear issues.
People also search for: dog ear infection treatment · beagle ear membrane healing · epidermal growth factor for dogs
Abstract
BACKGROUND: Tympanic membrane epithelial migration (TMEM) protects the external ear canal from infections and aids in the removal of keratin. Epidermal growth factor (EGF) accelerates tissue regeneration by stimulating cell proliferation and migration. HYPOTHESIS/OBJECTIVES: Topical application of EGF will accelerate the canine TMEM rate. ANIMALS: Three male beagle dogs. MATERIALS AND METHODS: Six TMs were divided into control and experimental phases. The experimental phase was assessed 2 weeks after the control phase and involved weekly EGF applications (0.5 mg/mL; 25 μg in 50 μL of phosphate-buffered saline), while the control phase involved no treatment. TMEM was assessed by applying ink spots to the TM and tracking migration on Day (D)0, D7, D14 and D21. A paired Student's t-test was used to compare the daily TMEM rates between phases. RESULTS: The EGF-treated phase had a significantly higher mean TMEM rate (235.0 ± 91.76 μm/day) than the control phase (146.83 ± 69.95 μm/day), showing a 60.1% increase (p < 0.05). The mean difference was 88.2 μm/day (95% confidence interval [CI]: 36.8-139.5). This difference was statistically significant based on both the paired t-test (p = 0.020) and Wilcoxon signed-rank test (p = 0.031). No differences were noted between the left and right ears, and no adverse effects occurred. CONCLUSIONS AND CLINICAL RELEVANCE: These results suggest that EGF increases TMEM in dogs. These initial findings suggest potential clinical applications of EGF. Further studies are needed to validate these findings and evaluate their therapeutic potential.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41290556/